BMP4 Blocking Peptide for STJ500276 peptide (STJ503728)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 184-197 on rat BMP4 protein, peptide was covalently modified. Sequence: VMKPPAPGHLIC
General Information
| Short Description | BMP4 Blocking Peptide for STJ500276 is synthetically produced from the 184-197 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic peptide taken within amino acid region 184-197 on rat BMP4 protein, peptide was covalently modified. Sequence: VMKPPAPGHLIC |
| Immunogen Region | 184-197 |
| Specificity | This blocking peptide is recommended for use in combination with BMP4 antibody, STJ500276 |
Additional Info
| Background | Invovled in chemoattractant activity and heparin binding |
Information sourced from Uniprot.org